Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_assertion type Assertion NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_head.
- NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_assertion wasGeneratedBy ECO_0000203 NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_provenance.
- NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_assertion wasDerivedFrom befree-20140225 NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_provenance.
- NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_assertion SIO_000772 9679568 NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_provenance.
- NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_assertion evidence source_evidence_literature NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_provenance.
- NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_assertion description "[Phase 1 clinical evaluation of oltipraz has demonstrated its ability to induce GST activity as well as the level of transcripts encoding gamma-glutamylcysteine synthetase (gamma-GCS) and DT-diaphorase in the colon mucosa of individuals at increased risk for colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324757.RA41JZ4X-QuO4wz4fImJKNDbHwZKKVZYEh8pfKLuh4RPQ130_provenance.